Summary
A 33-year-old woman was treated for severe aplastic anemia with norethandrolone over a period of four years, with a cumulative dose of 25 g. In the fifth year of therapy two intrahepatic tumors were detected and were classified as hepatocellular carcinoma and as focal nodular hyperplasia, respectively.
This is a preview of subscription content, log in via an institution to check access.
References
Anthony PP (1975) Hepatoma associated with androgenic steroids. Lancet 7908: 685
Boyd PR, Mark GJ (1977) Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years. Cancer 40: 1765
Chopra S, Edelstein A, Koff RS, Zimelman AP, Lacson A, Neiman RS (1978) Peliosis hepatis in hematologic disease. JAMA 240: 1153
Edmondson HA, Henderson B, Benton B (1976) Liver cell adenomas associated with use of oral contraceptives. N Engl J Med 294: 470
Farrel GC, Uren RF, Perkins KW, Joshua De, Bairs PJ, Kronenberg H (1975) Androgen induced hepatoma. Lancet 7904: 430
Goldfarb S (1976) Sex hormones and hepatic neoplasia. Cancer Res 36: 2584–2588
Gordon BS, Wolf J, Krause T, Shai F (1960) Peliosis hepatis and cholestasis following administration of norethandrolone. Am J Clin Pathol 33: 156
Johnson FL, Lerner KG, Siegel M, Thomas ED, Feagler JR, Majerus PW, Hartman JR (1972) Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 7790: 1273
Leevy CM, Cherrick GR, Davidson CS (1961) Observations on norethandrolone-induced abnormalities in plasma decay of sulfobromophtalein and indocyanine green. J Lab Clin Med 57: 918
Mays T, Christopherson WM, Mahr ME, Williams HC (1976) Hepatic changes in young women ingesting contraceptive steroids. JAMA 235: 730
Najean Y (1981) For Joint group for the study of aplastic and refractory anemias Long-term follow-up in patients with aplastic anemia. Am J Med 71: 543
Saheb F (1980) Absence of peliosis hepatis in patients receiving testosterone-enanthat. Hepatogastroenterology 27: 432
Scheuer A, Lehmann FG (1977) Lebertumoren bei Therapie mit Kontrazeptiva und Anabolika. Internist 18: 208
Scheuer A, Gerdes H, Lehmann FG (1979) Anabolika und Lebertumoren. Dtsch Med Wochenschr 104: 779
Speck B, Gratwohl A, Nissen C, Leibundgut U, Ruggero D, Osterwalder B, Burri HP, Cornu P, Jeannet M (1981) Treatment of severe aplastic anemia with antilymphocyte globulin or bone marrow transplantation. Br Med J 282: 860
Speck B, Gratwohl A, Nissen C, Osterwalder B, Signer E, Jeannet M (1984) Treatment of severe aplastic anemia. In: Aplastic anemia: stem cell biology and advances in treatment. Alan R Liss, Inc, New York, p 249
Treuner J, Niethammer D, Flach A, Fischbach H, Schenk W (1980) Hepatozelluläres Karzinom nach Oxymetholonbehandlung. Med Welt 31: 952
Tucker RA (1982) Drugs and liver disease: a tabular compilation of drugs and the histopathological changes that can occur in the liver. Drug Intell Clin Pharm 76: 569
Westaby D, Portman B, Williams R (1983) Androgen related primary hepatic tumors in non-Fanconi patients. Cancer 51: 1947
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Serke, S., Dienemann, D., Speck, B. et al. Hepatocellular carcinoma and focal nodular hyperplasia associated with norethandrolone-therapy: A case report. Blut 52, 111–116 (1986). https://doi.org/10.1007/BF00321073
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00321073